2型糖尿病和Helicobacter pylori在临床人群中的根除
Grace Sekaya, Frances Wang1, HannahSofia Brown2
1the Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina.
Southern medical journal
|April 3, 2024
概括
2型糖尿病 (T2DM) 没有影响Helicobacter pylori根除率. 这一发现支持H. pylori治疗试验,以预防高风险T2DM人群的胃癌.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 内分泌学 在内分泌学.
背景情况:
- 根除Helicobacter pylori可以降低胃癌的风险.
- 2型糖尿病 (T2DM) 与胃癌风险增加有关.
- T2DM对H. pylori治疗结果的影响尚未得到充分证实.
研究的目的:
- 评估T2DM是否会增加治疗后持续性H. pylori感染的风险.
- 为了比较患有T2DM和没有T2DM的患者的H. pylori根除率.
主要方法:
- 对H. pylori阳性患者没有肠道转质形成的回顾性队列研究.
- 患者按种族分层 (黑人和白人).
- 对年龄,种族和保险状况进行调整后的物流回归分析.
主要成果:
- 在患有T2DM (81.1%) 和没有T2DM (81.2%) 的患者中,H. pylori根除率相似.
- 二次性糖尿病与持续性H. pylori感染的显著增加风险没有关联 (OR 1.40;95% CI 0.49-3.99).
结论:
- 根除H. pylori的有效性不受T2DM状态的影响.
- 在高风险人群中,包括患有T2DM的人群中,研究H. pylori根除用于胃癌预防的临床试验是有必要的.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
390
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
390
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
116
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
116
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Gastritis III: Clinical Manifestations and Management
235
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
235
Peptic Ulcer Disease I: Introduction
168
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168
Peptic Ulcer Disease IV: Management
91
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
91


